Muhamed Baljevic, MD

Member Biographical Information

Muhamed Baljevic, MD


Project Interest

Focusing on plasma cell dyscrasias, more specifically, PI resistance in MM. Opening a phase I/II study of c-MET inhibitor as a rational way to salvage PI resistance in rrMM. Interested to develop new treatment strategies for rrMM. Planning to study molecular signatures of various dyscrasia overlaps.


Link to Publications

Department of Oncology and Hematology

Link to Faculty Bio